Navigation Links
AccuVein Signs Multiple-Country Distribution Agreement in Europe for Vein Illumination Device

COLD SPRING HARBOR, N.Y., Oct. 19 /PRNewswire/ -- AccuVein LLC today announced a five-year agreement with the Ferrer Group, a leading international pharmaceutical and medical devices distribution company, providing the AccuVein AV300, the world's first hand-held, non-contact vein illumination device, to customers in Greece, Spain and Portugal. The AccuVein AV300 helps healthcare professionals locate veins for blood draw, IV infusion and blood donation by projecting a pattern of light on a patient's skin that reveals vein position.

"Ferrer Group's broad customer base share a common desire - to use advanced medical technology products that add value to reducing costs and improving patient care," said Jose Luis Lirio, Ferrer Group. "We're pleased to bring the world's only portable vein illumination device into our distribution."

"This agreement significantly expands the AV300's global availability into these important markets," said Stephen P. Conlon, President of AccuVein. "Healthcare practitioners in Greece, Spain and Portugal now have access to the device to reduce time and effort in accessing veins."

For more information on the AccuVein AV300, please visit

About AccuVein

AccuVein applies advanced technologies to important healthcare challenges. Their innovative AV300 allows practitioners to see a map on the patient's skin of the position of peripheral veins, helping caregivers locate these veins while they perform the most common invasive medical procedure - venipuncture. Built using AccuVein's expertise in medical device miniaturization and user-intuitive design, the AV300 is the world's first portable, non-contact vein illumination solution. With more than a dozen patents filed worldwide, AccuVein demonstrates an ongoing commitment to invest in improving patient care and patient satisfaction.

For more information on the AccuVein AV300, please visit

About Ferrer Group

Ferrer Group is comprised of over 50 companies operating in Pharmacy, Food and Fine Chemicals, three key areas to assist in improving health and quality of life of people. Grupo Ferrer Internacional serves customers in France, Italy, Belgium, Portugal, and Greece, as well as in Spain, Germany, the Middle East, South America, Africa, and the Far East. Grupo Ferrer Internacional, S.A. was founded in 1959 and is based in Barcelona, Spain.


Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
2. StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
3. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
4. New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings
5. New AVEENO(R) Eczema Care Product Line Offers Breakthrough Formulas to Help Manage the Signs and Symptoms of Eczema
6. ALS Therapy Development Institute Signs Collaboration Agreement with the Allen Institute for Brain Science
7. Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Companys MicroRNA Technology
8. Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute
9. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
10. Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
11. ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies
Post Your Comments:
(Date:12/1/2015)... Va. , Dec. 1, 2015  AccuTEC ... unveiled a new corporate logo and brand identity ... the design and engineering of bladed products where ... --> --> Serving manufacturers ... glass, and auto glass equipment, AccuTEC,s product lines ...
(Date:12/1/2015)... , Dec. 1, 2015 During the ... San Francisco, CA , Medinol ... the coronary marketplace. During a satellite symposium, "The ... Design to Minimize Restenosis", a renowned physician panel ... Medinol NIRxcell™ CoCr Coronary Stent System and the ...
(Date:12/1/2015)... ) has ... and Disposables Market by product, by Animal - ... offering. --> ) has announced ... Disposables Market by product, by Animal - Global ... --> Research and Markets ( ...
Breaking Medicine Technology:
(Date:12/1/2015)... Angeles, CA (PRWEB) , ... December 01, 2015 , ... ... coalition of obesity groups has filed a discrimination claim against the U.S. Department of ... coverage in their Affordable Care Act (ACA) plans are breaking the clause in the ...
(Date:12/1/2015)... Fla. (PRWEB) , ... December 01, 2015 , ... ... number of leadless pacemakers in the U.S. and is the only hospital in ... from the largest clinical data presentation of transcatheter pacing patients were revealed recently ...
(Date:12/1/2015)... Houston, TX (PRWEB) , ... December 01, 2015 , ... ... owner of Vitenas Cosmetic Surgery, has been named by MedEsthetics magazine as the Best ... best of the best among the many elite aesthetic physicians honored by the industry ...
(Date:12/1/2015)... ... 2015 , ... Growth in medical payments per workers’ compensation claim in Louisiana ... and nonhospital care, according to a recent study by the Workers Compensation Research Institute ... found medical payments per claim with more than seven days of lost time continued ...
(Date:12/1/2015)... York, NY (PRWEB) , ... December 01, 2015 ... ... epidemic in the 1980s we have seen vast improvements in scientific research and ... made significant strides, providing increased hope and relief to those affected by HIV/AIDS. ...
Breaking Medicine News(10 mins):